These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 28698037)
1. Cefazolin versus anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a narrative review. Loubet P; Burdet C; Vindrios W; Grall N; Wolff M; Yazdanpanah Y; Andremont A; Duval X; Lescure FX Clin Microbiol Infect; 2018 Feb; 24(2):125-132. PubMed ID: 28698037 [TBL] [Abstract][Full Text] [Related]
2. β-Lactam Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Comparative Review of Cefazolin versus Antistaphylococcal Penicillins. Li J; Echevarria KL; Traugott KA Pharmacotherapy; 2017 Mar; 37(3):346-360. PubMed ID: 28035690 [TBL] [Abstract][Full Text] [Related]
3. Optimal treatment of MSSA bacteraemias: a meta-analysis of cefazolin versus antistaphylococcal penicillins. Bidell MR; Patel N; O'Donnell JN J Antimicrob Chemother; 2018 Oct; 73(10):2643-2651. PubMed ID: 30085140 [TBL] [Abstract][Full Text] [Related]
4. Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in Korea. Lee S; Song KH; Jung SI; Park WB; Lee SH; Kim YS; Kwak YG; Kim YK; Kiem SM; Kim HI; Kim ES; Park KH; Kim NJ; Jang HC; Kim HB; Clin Microbiol Infect; 2018 Feb; 24(2):152-158. PubMed ID: 28694202 [TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of trials comparing cefazolin to antistaphylococcal penicillins in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia. Rindone JP; Mellen CK Br J Clin Pharmacol; 2018 Jun; 84(6):1258-1266. PubMed ID: 29600576 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of cloxacillin versus cefazolin for methicillin-susceptible Burdet C; Loubet P; Le Moing V; Vindrios W; Esposito-Farèse M; Linard M; Ferry T; Massias L; Tattevin P; Wolff M; Vandenesch F; Grall N; Quintin C; Mentré F; Duval X; Lescure FX; BMJ Open; 2018 Sep; 8(8):e023151. PubMed ID: 30173161 [TBL] [Abstract][Full Text] [Related]
7. A large retrospective cohort study of cefazolin compared with flucloxacillin for methicillin-susceptible Staphylococcus aureus bacteraemia. Davis JS; Turnidge J; Tong S Int J Antimicrob Agents; 2018 Aug; 52(2):297-300. PubMed ID: 29499317 [TBL] [Abstract][Full Text] [Related]
8. Cefazolin versus anti-staphylococcal penicillins for the treatment of patients with Staphylococcus aureus bacteraemia. Weis S; Kesselmeier M; Davis JS; Morris AM; Lee S; Scherag A; Hagel S; Pletz MW Clin Microbiol Infect; 2019 Jul; 25(7):818-827. PubMed ID: 30928559 [TBL] [Abstract][Full Text] [Related]
9. Comparative outcomes of cefazolin versus antistaphylococcal penicillins in methicillin-susceptible Staphylococcus aureus infective endocarditis: a post hoc analysis of a prospective multicentre French cohort study. Lecomte R; Bourreau A; Deschanvres C; Issa N; Le Turnier P; Gaborit B; Chauveau M; Leroy AG; Le Tourneau T; Caillon J; Camou F; Boutoille D Clin Microbiol Infect; 2021 Jul; 27(7):1015-1021. PubMed ID: 32950711 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of cefazolin versus antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia: a systematic review and meta-analysis. Shi C; Xiao Y; Zhang Q; Li Q; Wang F; Wu J; Lin N BMC Infect Dis; 2018 Oct; 18(1):508. PubMed ID: 30305037 [TBL] [Abstract][Full Text] [Related]
11. Implementation of a cefazolin-based stewardship pathway for methicillin-susceptible Staphylococcus aureus bloodstream infections paired with infectious diseases consultation. Lee BJ; Rao SN; Wang SK; Lee JY; Lakada IY; Gilbert EM; Barr VO; Postelnick MJ; Sutton SH; Zembower TR; Bolon M; Scheetz MH; Rhodes NJ Int J Antimicrob Agents; 2017 May; 49(5):650-654. PubMed ID: 28279787 [TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study. Bai AD; Showler A; Burry L; Steinberg M; Ricciuto DR; Fernandes T; Chiu A; Raybardhan S; Science M; Fernando E; Tomlinson G; Bell CM; Morris AM J Antimicrob Chemother; 2015 May; 70(5):1539-46. PubMed ID: 25614044 [TBL] [Abstract][Full Text] [Related]
13. Antistaphylococcal penicillins versus cephalosporins for definitive treatment of meticillin-susceptible Staphylococcus aureus bacteraemia: a systematic review and meta-analysis. Vardakas KZ; Apiranthiti KN; Falagas ME Int J Antimicrob Agents; 2014 Dec; 44(6):486-92. PubMed ID: 25311850 [TBL] [Abstract][Full Text] [Related]
15. Clinical implications of cefazolin inoculum effect and β-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia. Lee S; Kwon KT; Kim HI; Chang HH; Lee JM; Choe PG; Park WB; Kim NJ; Oh MD; Song DY; Kim SW Microb Drug Resist; 2014 Dec; 20(6):568-74. PubMed ID: 25000230 [TBL] [Abstract][Full Text] [Related]
16. Comparison of cefazolin versus oxacillin for treatment of complicated bacteremia caused by methicillin-susceptible Staphylococcus aureus. Li J; Echevarria KL; Hughes DW; Cadena JA; Bowling JE; Lewis JS Antimicrob Agents Chemother; 2014 Sep; 58(9):5117-24. PubMed ID: 24936596 [TBL] [Abstract][Full Text] [Related]
17. Cefazolin vs. anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections in acutely ill adult patients: Results of a systematic review and meta-analysis. Lee BJ; Wang SK; Constantino-Corpuz JK; Apolinario K; Nadler B; McDanel JS; Scheetz MH; Rhodes NJ Int J Antimicrob Agents; 2019 Mar; 53(3):225-233. PubMed ID: 30476572 [TBL] [Abstract][Full Text] [Related]
18. Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia. Monogue ML; Ortwine JK; Wei W; Eljaaly K; Bhavan KP J Infect Public Health; 2018; 11(5):727-731. PubMed ID: 29526442 [TBL] [Abstract][Full Text] [Related]
19. Post-treatment outcomes of ceftriaxone versus antistaphylococcal penicillins or cefazolin for definitive therapy of methicillin-susceptible Staphylococcus aureus bacteremia. Yetmar ZA; Khodadadi RB; Go JR; Chesdachai S; Abu Saleh OM Eur J Clin Microbiol Infect Dis; 2023 Apr; 42(4):423-430. PubMed ID: 36800065 [TBL] [Abstract][Full Text] [Related]
20. Cefazolin versus Nafcillin for Methicillin-Sensitive Staphylococcus aureus Bloodstream Infection in a California Tertiary Medical Center. Pollett S; Baxi SM; Rutherford GW; Doernberg SB; Bacchetti P; Chambers HF Antimicrob Agents Chemother; 2016 Aug; 60(8):4684-9. PubMed ID: 27216053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]